These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 25271887)
1. Long term natural history data in ambulant boys with Duchenne muscular dystrophy: 36-month changes. Pane M; Mazzone ES; Sivo S; Sormani MP; Messina S; D'Amico A; Carlesi A; Vita G; Fanelli L; Berardinelli A; Torrente Y; Lanzillotta V; Viggiano E; D Ambrosio P; Cavallaro F; Frosini S; Barp A; Bonfiglio S; Scalise R; De Sanctis R; Rolle E; Graziano A; Magri F; Palermo C; Rossi F; Donati MA; Sacchini M; Arnoldi MT; Baranello G; Mongini T; Pini A; Battini R; Pegoraro E; Previtali S; Bruno C; Politano L; Comi GP; Bertini E; Mercuri E PLoS One; 2014; 9(10):e108205. PubMed ID: 25271887 [TBL] [Abstract][Full Text] [Related]
2. North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy. Mazzone E; Martinelli D; Berardinelli A; Messina S; D'Amico A; Vasco G; Main M; Doglio L; Politano L; Cavallaro F; Frosini S; Bello L; Carlesi A; Bonetti AM; Zucchini E; De Sanctis R; Scutifero M; Bianco F; Rossi F; Motta MC; Sacco A; Donati MA; Mongini T; Pini A; Battini R; Pegoraro E; Pane M; Pasquini E; Bruno C; Vita G; de Waure C; Bertini E; Mercuri E Neuromuscul Disord; 2010 Nov; 20(11):712-6. PubMed ID: 20634072 [TBL] [Abstract][Full Text] [Related]
3. 24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy. Mazzone ES; Pane M; Sormani MP; Scalise R; Berardinelli A; Messina S; Torrente Y; D'Amico A; Doglio L; Viggiano E; D'Ambrosio P; Cavallaro F; Frosini S; Bello L; Bonfiglio S; De Sanctis R; Rolle E; Bianco F; Magri F; Rossi F; Vasco G; Vita G; Motta MC; Donati MA; Sacchini M; Mongini T; Pini A; Battini R; Pegoraro E; Previtali S; Napolitano S; Bruno C; Politano L; Comi GP; Bertini E; Mercuri E PLoS One; 2013; 8(1):e52512. PubMed ID: 23326337 [TBL] [Abstract][Full Text] [Related]
4. Strong correlation between the 6-minute walk test and accelerometry functional outcomes in boys with Duchenne muscular dystrophy. Davidson ZE; Ryan MM; Kornberg AJ; Walker KZ; Truby H J Child Neurol; 2015 Mar; 30(3):357-63. PubMed ID: 24762862 [TBL] [Abstract][Full Text] [Related]
5. Ambulatory capacity and disease progression as measured by the 6-minute-walk-distance in Duchenne muscular dystrophy subjects on daily corticosteroids. Goemans N; van den Hauwe M; Wilson R; van Impe A; Klingels K; Buyse G Neuromuscul Disord; 2013 Aug; 23(8):618-23. PubMed ID: 23770101 [TBL] [Abstract][Full Text] [Related]
7. The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter study. McDonald CM; Henricson EK; Abresch RT; Florence JM; Eagle M; Gappmaier E; Glanzman AM; ; Spiegel R; Barth J; Elfring G; Reha A; Peltz S Muscle Nerve; 2013 Sep; 48(3):343-56. PubMed ID: 23681930 [TBL] [Abstract][Full Text] [Related]
8. Categorizing natural history trajectories of ambulatory function measured by the 6-minute walk distance in patients with Duchenne muscular dystrophy. Mercuri E; Signorovitch JE; Swallow E; Song J; Ward SJ; ; Neuromuscul Disord; 2016 Sep; 26(9):576-83. PubMed ID: 27423700 [TBL] [Abstract][Full Text] [Related]
9. Stride Velocity 95th Centile Detects Decline in Ambulatory Function Over Shorter Intervals than the 6-Minute Walk Test or North Star Ambulatory Assessment in Duchenne Muscular Dystrophy. Rabbia M; Guridi Ormazabal M; Staunton H; Veenstra K; Eggenspieler D; Annoussamy M; Servais L; Strijbos P J Neuromuscul Dis; 2024; 11(3):701-714. PubMed ID: 38640165 [TBL] [Abstract][Full Text] [Related]
10. Six-minute walk test versus two-minute walk test in children with Duchenne muscular dystrophy: Is more time more information? Vill K; Ille L; Schroeder SA; Blaschek A; Müller-Felber W Eur J Paediatr Neurol; 2015 Nov; 19(6):640-6. PubMed ID: 26455815 [TBL] [Abstract][Full Text] [Related]
11. The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy. McDonald CM; Henricson EK; Han JJ; Abresch RT; Nicorici A; Elfring GL; Atkinson L; Reha A; Hirawat S; Miller LL Muscle Nerve; 2010 Apr; 41(4):500-10. PubMed ID: 19941337 [TBL] [Abstract][Full Text] [Related]
12. The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study. McDonald CM; Henricson EK; Abresch RT; Florence J; Eagle M; Gappmaier E; Glanzman AM; ; Spiegel R; Barth J; Elfring G; Reha A; Peltz SW Muscle Nerve; 2013 Sep; 48(3):357-68. PubMed ID: 23674289 [TBL] [Abstract][Full Text] [Related]
13. Comparison of Long-term Ambulatory Function in Patients with Duchenne Muscular Dystrophy Treated with Eteplirsen and Matched Natural History Controls. Mendell JR; Khan N; Sha N; Eliopoulos H; McDonald CM; Goemans N; Mercuri E; Lowes LP; Alfano LN; J Neuromuscul Dis; 2021; 8(4):469-479. PubMed ID: 33523015 [TBL] [Abstract][Full Text] [Related]
14. Age-related longitudinal changes in metabolic energy expenditure during walking in boys with Duchenne muscular dystrophy. Brehm MA; Kempen JC; van der Kooi AJ; de Groot IJ; van den Bergen JC; Verschuuren JJ; Niks EH; Harlaar J PLoS One; 2014; 9(12):e115200. PubMed ID: 25506914 [TBL] [Abstract][Full Text] [Related]
15. Ankle contractures and functional motor decline in Duchenne muscular dystrophy. Woof AL; Selby K; Harris SR Brain Dev; 2022 Feb; 44(2):105-113. PubMed ID: 34629214 [TBL] [Abstract][Full Text] [Related]